{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:11:23Z","timestamp":1786605083853,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1DA040317"],"award-info":[{"award-number":["UG1DA040317"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01MD007658"],"award-info":[{"award-number":["R01MD007658"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12889-018-5982-8","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T17:28:47Z","timestamp":1535563727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["National trends and characteristics of inpatient detoxification for drug use disorders in the United States"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4868-0095","authenticated-orcid":false,"given":"He","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Tzy","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"5982_CR1","volume-title":"Detoxification and substance abuse treatment. Treatment Improvement Protocol (TIP) Series 45. DHHS Publication No. (SMA) 06\u20134131","author":"Center for Substance Abuse Treatment (CSAT)","year":"2006","unstructured":"Center for Substance Abuse Treatment (CSAT). Detoxification and substance abuse treatment. Treatment Improvement Protocol (TIP) Series 45. DHHS Publication No. (SMA) 06\u20134131. Rockville: Substance Abuse and Mental Health Services Administration; 2006. \n                    https:\/\/store.samhsa.gov\/shin\/content\/SMA13-4131\/SMA13-4131.pdf\n                    \n                  . Accessed 11 Dec 2016"},{"key":"5982_CR2","volume-title":"Treatments for substance use disorders","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2016","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Treatments for substance use disorders. Rockville: Substance Abuse and Mental Health Services Administration; 2016. \n                    https:\/\/www.samhsa.gov\/treatment\/substance-use-disorders\n                    \n                  . Accessed 12 Oct 2017"},{"key":"5982_CR3","volume-title":"Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2004\u20132014. National Admissions to Substance Abuse Treatment Services. BHSIS Series S-84, HHS Publication No. (SMA) 16-4986","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2016","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2004\u20132014. National Admissions to Substance Abuse Treatment Services. BHSIS Series S-84, HHS Publication No. (SMA) 16-4986. Rockville: Substance Abuse and Mental Health Services Administration; 2016. \n                    https:\/\/wwwdasis.samhsa.gov\/dasis2\/teds_pubs\/2014_teds_rpt_natl.pdf\n                    \n                  . Accessed 12 Oct 2017"},{"key":"5982_CR4","volume-title":"Principles of drug addiction treatment: a research-based guide","author":"National Institute of Drug Abuse (NIDA)","year":"2012","unstructured":"National Institute of Drug Abuse (NIDA). Principles of drug addiction treatment: a research-based guide. 3rd ed; 2012. \n                    https:\/\/www.drugabuse.gov\/publications\/principles-drug-addiction-treatment-research-based-guide-third-edition\n                    \n                  . Accessed 10 Mar 2017","edition":"3"},{"key":"5982_CR5","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1056\/NEJMra020617","volume":"348","author":"TR Kosten","year":"2003","unstructured":"Kosten TR, O'Connor PG. Management of drug and alcohol withdrawal. N Engl J Med. 2003;348:1786\u201395.","journal-title":"N Engl J Med"},{"key":"5982_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.drugalcdep.2009.04.008","volume":"104","author":"BD Stein","year":"2009","unstructured":"Stein BD, Kogan JN, Sorbero M. Substance abuse detoxification and residential treatment among Medicaid-enrolled adults: rates and duration of subsequent treatment. Drug Alcohol Depend. 2009;104:100\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"5982_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jsat.2016.07.010","volume":"70","author":"C Timko","year":"2016","unstructured":"Timko C, Schultz NR, Britt J, Cucciare MA. Transitioning from detoxification to substance use disorder treatment: facilitators and barriers. J Subst Abus Treat. 2016;70:64\u201372.","journal-title":"J Subst Abus Treat"},{"key":"5982_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/SAR.S15151","volume":"1","author":"LT Wu","year":"2010","unstructured":"Wu LT, Ling W, Burchett B, Blazer DG, Shostak J, Woody GE. Gender and racial\/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: results from the National Drug Abuse Treatment Clinical Trials Network. Subst Abuse Rehabil. 2010;1:13\u201322.","journal-title":"Subst Abuse Rehabil"},{"key":"5982_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jsat.2010.08.007","volume":"40","author":"E Day","year":"2011","unstructured":"Day E, Strang J. Outpatient versus inpatient opioid detoxification: a randomized controlled trial. J Subst Abus Treat. 2011;40:56\u201366.","journal-title":"J Subst Abus Treat"},{"key":"5982_CR10","first-page":"44","volume":"22","author":"M Hayashida","year":"1998","unstructured":"Hayashida M. An overview of outpatient and inpatient detoxification. Alcohol Health Res World. 1998;22:44\u20136.","journal-title":"Alcohol Health Res World"},{"key":"5982_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0740-5472(02)00271-4","volume":"23","author":"TL Mark","year":"2002","unstructured":"Mark TL, Dilonardo JD, Chalk M, Coffey RM. Trends in inpatient detoxification services, 1992\u20131997. J Subst Abus Treat. 2002;23:253\u201360.","journal-title":"J Subst Abus Treat"},{"key":"5982_CR12","volume-title":"2015 National Survey on Drug Use and Health: detailed tables","author":"Center for Behavioral Health Statistics and Quality (CBHSQ)","year":"2016","unstructured":"Center for Behavioral Health Statistics and Quality (CBHSQ). 2015 National Survey on Drug Use and Health: detailed tables. Rockville: Substance Abuse and Mental Health Services Administration; 2016. \n                    https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-DetTabs-2015\/NSDUH-DetTabs-2015\/NSDUH-DetTabs-2015.pdf\n                    \n                  . Accessed 12 Oct 2017"},{"key":"5982_CR13","volume-title":"Drug overdose deaths in the United States, 1999\u20132015. NCHS data brief, no 273","author":"H Hedegaard","year":"2017","unstructured":"Hedegaard H, Warner M, Mini\u00f1o AM. Drug overdose deaths in the United States, 1999\u20132015. NCHS data brief, no 273. Hyattsville: National Center for Health Statistics; 2017. \n                    https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db273.htm\n                    \n                  . Accessed 15 Aug 2017"},{"key":"5982_CR14","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","volume":"65","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths \u2014 United States, 2010\u20132015. MMWR Morb Mortal Wkly Rep. 2016;65:1445\u201352.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5982_CR15","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1001\/jama.2017.13358","volume":"318","author":"LO Gostin","year":"2017","unstructured":"Gostin LO, Hodge JG Jr, Noe SA. Reframing the opioid epidemic as a national emergency. JAMA. 2017;318:1539\u201340.","journal-title":"JAMA"},{"key":"5982_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1001\/jama.2015.12397","volume":"314","author":"LS Nelson","year":"2015","unstructured":"Nelson LS, Juurlink DN, Perrone J. Addressing the opioid epidemic. JAMA. 2015;314:1453\u20134.","journal-title":"JAMA"},{"key":"5982_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2017.8913","volume":"318","author":"A Schuchat","year":"2017","unstructured":"Schuchat A, Houry D, Guy GP. New data on opioid use and prescribing in the United States. JAMA. 2017;318:425\u20136.","journal-title":"JAMA"},{"key":"5982_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0740-5472(02)00302-1","volume":"23","author":"RC Callaghan","year":"2002","unstructured":"Callaghan RC, Cunningham JA. Gender differences in detoxification: predictors of completion and re-admission. J Subst Abus Treat. 2002;23:399\u2013407.","journal-title":"J Subst Abus Treat"},{"key":"5982_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","volume":"169","author":"LT Wu","year":"2016","unstructured":"Wu LT, Zhu H, Swartz MS. Treatment utilization among persons with opioid use disorder in the United States. Drug Alcohol Depend. 2016;169:117\u201327.","journal-title":"Drug Alcohol Depend"},{"key":"5982_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jamapsychiatry.2015.2132","volume":"73","author":"BF Grant","year":"2016","unstructured":"Grant BF, Saha TD, Ruan WJ, et al. Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on alcohol and related conditions\u2013III. JAMA Psychiatry. 2016;73:39\u201347.","journal-title":"JAMA Psychiatry"},{"key":"5982_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jsat.2010.09.001","volume":"40","author":"SJ Haley","year":"2011","unstructured":"Haley SJ, Dugosh KL, Lynch KG. Performance contracting to engage detoxification-only patients into continued rehabilitation. J Subst Abus Treat. 2011;40:123\u201331.","journal-title":"J Subst Abus Treat"},{"key":"5982_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/10550887.2011.554776","volume":"30","author":"E Carrier","year":"2011","unstructured":"Carrier E, McNeely J, Lobach I, Tay S, Gourevitch MN, Raven MC. Factors associated with frequent utilization of crisis substance use detoxification services. J Addict Dis. 2011;30:116\u201322.","journal-title":"J Addict Dis"},{"key":"5982_CR23","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","volume":"174","author":"JM Liebschutz","year":"2014","unstructured":"Liebschutz JM, Crooks D, Herman D, Anderson B, Tsui J, Meshesha LZ, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174:1369\u201376.","journal-title":"JAMA Intern Med"},{"key":"5982_CR24","unstructured":"Mark T, Vandivort-Warren R, Stocks C, Levit K, Owens P, Buck J, Coffey R. Treatment for substance use disorders in community hospitals: U.S. Agency for Healthcare Research and Quality (AHRQ); 2010. \n                    http:\/\/www.hcup-us.ahrq.gov\/reports.jsp\n                    \n                  . Accessed 12 Oct 2017"},{"key":"5982_CR25","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1176\/appi.ps.201600339","volume":"68","author":"S Reif","year":"2017","unstructured":"Reif S, Acevedo A, Garnick DW, Fullerton CA. Reducing behavioral health inpatient readmissions for people with substance use disorders: do follow-up services matter? Psychiatr Serv. 2017;68:810\u20138.","journal-title":"Psychiatr Serv"},{"key":"5982_CR26","doi-asserted-by":"publisher","unstructured":"Day E, Ison J, Strang J. Inpatient versus other settings for detoxification for opioid dependence. Cochrane Database Syst Rev. 2005:Art. No.: CD004580. \n                    https:\/\/doi.org\/10.1002\/14651858.CD004580.pub2\n                    \n                  .","DOI":"10.1002\/14651858.CD004580.pub2"},{"issue":"Suppl 1","key":"5982_CR27","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/j.jsat.2009.12.012","volume":"38","author":"BK Campbell","year":"2010","unstructured":"Campbell BK, Tillotson CJ, Choi D, Bryant K, DiCenzo J, Provost SE, et al. Predicting outpatient treatment entry following detoxification for injection drug use: the impact of patient and program factors. J Subst Abus Treat. 2010;38(Suppl 1):S87\u201396.","journal-title":"J Subst Abus Treat"},{"key":"5982_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0740-5472(03)00039-4","volume":"24","author":"TL Mark","year":"2003","unstructured":"Mark TL, Dilonardo JD, Chalk M, Coffey R. Factors associated with the receipt of treatment following detoxification. J Subst Abus Treat. 2003;24:299\u2013304.","journal-title":"J Subst Abus Treat"},{"key":"5982_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.drugalcdep.2014.07.020","volume":"143","author":"B Nosyk","year":"2014","unstructured":"Nosyk B, Li L, Evans E. Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991\u20132012. Drug Alcohol Depend. 2014;143:149\u201357.","journal-title":"Drug Alcohol Depend"},{"key":"5982_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4065\/84.3.255","volume":"84","author":"DJ Alfandre","year":"2009","unstructured":"Alfandre DJ. \u201cI\u2019m going home\u201d: discharges against medical advice. Mayo Clin Proc. 2009;84:255\u201360.","journal-title":"Mayo Clin Proc"},{"key":"5982_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/ADM.0b013e318231de51","volume":"6","author":"AY Walley","year":"2012","unstructured":"Walley AY, Paasche-Orlow M, Lee EC, Forsythe S, Chetty VK, Mitchell S, et al. Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis. J Addict Med. 2012;6:50\u20136.","journal-title":"J Addict Med"},{"key":"5982_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/10550887.2010.489452","volume":"29","author":"DR Kenne","year":"2010","unstructured":"Kenne DR, Boros AP, Fischbein RL. Characteristics of opiate users leaving detoxification treatment against medical advice. J Addict Dis. 2010;29:383\u201394.","journal-title":"J Addict Dis"},{"key":"5982_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1300\/J069v25n01_12","volume":"25","author":"RD Blondell","year":"2006","unstructured":"Blondell RD, Amadasu A, Servoss TJ, Smith SJ. Differences among those who complete and fail to complete inpatient detoxification. J Addict Dis. 2006;25:95\u2013104.","journal-title":"J Addict Dis"},{"key":"5982_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.drugalcdep.2006.12.019","volume":"89","author":"JD Wines","year":"2007","unstructured":"Wines JD, Saitz R, Horton NJ, Lloyd-Travaglini C, Samet JH. Overdose after detoxification: a prospective study. Drug Alcohol Depend. 2007;89:161\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"5982_CR35","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1056\/NEJMra1604339","volume":"375","author":"MA Schuckit","year":"2016","unstructured":"Schuckit MA. Treatment of opioid-use disorders. N Engl J Med. 2016;375:357\u201368.","journal-title":"N Engl J Med"},{"key":"5982_CR36","volume-title":"Healthcare Cost and Utilization Project (HCUP)","author":"HCUP Nationwide Inpatient Sample (NIS)","year":"2011","unstructured":"HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Rockville: Agency for Healthcare Research and Quality; 2011. \n                    www.hcup-us.ahrq.gov\/nisoverview.jsp"},{"key":"5982_CR37","unstructured":"American Hospital Association (AHA). Fast facts on US hospitals. 2017. \n                    http:\/\/www.aha.org\/research\/rc\/stat-studies\/fast-facts.shtml\n                    \n                  . Accessed 04 Jan 2017."},{"key":"5982_CR38","unstructured":"Centers for Medicare and Medicaid Services (CMS). ICD-9-CM Diagnosis and Procedure Codes: Abbreviated and Full Code Titles. 2014. \n                    https:\/\/www.cms.gov\/medicare\/coding\/ICD9providerdiagnosticcodes\/codes.html\n                    \n                  . Accessed 07 Apr 2016."},{"key":"5982_CR39","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1097\/BRS.0000000000000352","volume":"39","author":"H Yoshihara","year":"2014","unstructured":"Yoshihara H, Yoneoka D. Understanding the statistics and limitations of large database analyses. Spine. 2014;39:1311\u20132.","journal-title":"Spine"},{"key":"5982_CR40","volume-title":"Release 13","author":"Stata [computer program]","year":"2013","unstructured":"Stata [computer program]. Release 13. College Station: StataCorp LP; 2013."},{"key":"5982_CR41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/02791072.2010.10400554","volume":"42","author":"LK Ford","year":"2010","unstructured":"Ford LK, Zarate P. Closing the gaps: the impact of inpatient detoxification and continuity of care on client outcomes. J Psychoactive Drugs. 2010;42:303\u201314.","journal-title":"J Psychoactive Drugs"},{"key":"5982_CR42","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.drugalcdep.2017.11.009","volume":"183","author":"A Acevedo","year":"2017","unstructured":"Acevedo A, Lee MT, Garnick DW, Horgan CM, Ritter GA, Panas L, et al. Agency-level financial incentives and electronic reminders to improve continuity of care after discharge from residential treatment and detoxification. Drug Alcohol Depend. 2017;183:192\u2013200.","journal-title":"Drug Alcohol Depend"},{"key":"5982_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jsat.2017.09.012","volume":"82","author":"AE Quinn","year":"2017","unstructured":"Quinn AE, Hodgkin D, Perloff JN, Stewart MT, Brolin M, Lane N, et al. Design and impact of bundled payment for detox and follow-up care. J Subst Abus Treat. 2017;82:113\u201321.","journal-title":"J Subst Abus Treat"},{"key":"5982_CR44","first-page":"51","volume":"15","author":"S Steenrod","year":"2001","unstructured":"Steenrod S, Brisson A, McCarty D, Hodgkin D. Effects of managed care on programs and practices for the treatment of alcohol and drug dependence. Recent Dev Alcohol. 2001;15:51\u201371.","journal-title":"Recent Dev Alcohol"},{"key":"5982_CR45","volume-title":"ASAM patient placement criteria for the treatment of substance-related disorders, 2nd-revised (ASAM PPC-2R)","author":"American Society of Addiction Medicine (ASAM)","year":"2001","unstructured":"American Society of Addiction Medicine (ASAM). ASAM patient placement criteria for the treatment of substance-related disorders, 2nd-revised (ASAM PPC-2R). Chevy Chase: American Society of Addiction Medicine; 2001."},{"key":"5982_CR46","doi-asserted-by":"crossref","unstructured":"Maclean JC, Saloner B. The effect of public insurance expansions on substance use disorder treatment: evidence from the affordable care act. (no. w23342). Nat Bureau Econ Res. \n                    http:\/\/www.nber.org\/papers\/w23342\n                    \n                  . Accessed 20 Nov 2017","DOI":"10.3386\/w23342"},{"key":"5982_CR47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.drugalcdep.2014.01.006","volume":"137","author":"SE Spear","year":"2014","unstructured":"Spear SE. Reducing readmissions to detoxification: an interorganizational network perspective. Drug Alcohol Depend. 2014;137:76\u201382.","journal-title":"Drug Alcohol Depend"},{"key":"5982_CR48","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1081\/ADA-120037390","volume":"30","author":"P Green","year":"2004","unstructured":"Green P, Watts D, Poole S, Dhopesh V. Why patients sign out against medical advice (AMA): factors motivating patients to sign out AMA. Am J Drug Alcohol Abuse. 2004;30:489\u201393.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"5982_CR49","unstructured":"Centers for Medicare and Medicaid Services (CMS). About section 1115 demonstrations. 2015. \n                    https:\/\/www.medicaid.gov\/medicaid\/section-1115-demo\/about-1115\/index.html\n                    \n                  . Accessed 09 Mar 2017."},{"key":"5982_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jsat.2016.06.010","volume":"69","author":"H Padwa","year":"2016","unstructured":"Padwa H, Urada D, Gauthier P, Rieckmann T, Hurley B, Cr\u00e8vecouer-MacPhail D, et al. Organizing publicly funded substance use disorder treatment in the United States: moving toward a service system approach. J Subst Abus Treat. 2016;69:9\u201318.","journal-title":"J Subst Abus Treat"},{"key":"5982_CR51","unstructured":"Hughes A, Williams MR, Lipari RN, Bose J, Copello EAP, Kroutil LA. Prescription drug use and misuse in the United States: results from the 2015 National Survey on Drug Use and Health. NSDUH Data Review. 2016. \n                    https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-FFR2-2015\/NSDUH-FFR2-2015.htm\n                    \n                  . Accessed 08 Apr 2017."},{"key":"5982_CR52","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1513\/AnnalsATS.201701-022OC","volume":"14","author":"JP Stevens","year":"2017","unstructured":"Stevens JP, Wall MJ, Novack L, Marshall J, Hsu DJ, Howell MD. The critical care crisis of opioid overdoses in the United States. Ann Am Thorac Soc. 2017;14:1803\u20139.","journal-title":"Ann Am Thorac Soc"},{"key":"5982_CR53","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jsat.2016.07.004","volume":"69","author":"S Naeger","year":"2016","unstructured":"Naeger S, Mutter R, Ali MM, Mark T, Hughey L. Post-discharge treatment engagement among patients with an opioid-use disorder. J Subst Abus Treat. 2016;69:64\u201371.","journal-title":"J Subst Abus Treat"},{"key":"5982_CR54","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2147\/SAR.S18969","volume":"2","author":"LT Wu","year":"2011","unstructured":"Wu LT, Woody GE, Yang C, Mannelli P, Blazer DG. Differences in onset and abuse\/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on alcohol and related conditions. Subst Abuse Rehabi. 2011;2:77\u201388.","journal-title":"Subst Abuse Rehabi"},{"key":"5982_CR55","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016. JAMA. 2016;315:1624\u201345.","journal-title":"JAMA"},{"key":"5982_CR56","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1001\/jama.2017.13767","volume":"318","author":"HK Koh","year":"2017","unstructured":"Koh HK. Community-based prevention and strategies for the opioid crisis. JAMA. 2017;318:993\u20134.","journal-title":"JAMA"},{"key":"5982_CR57","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.drugalcdep.2017.02.006","volume":"175","author":"N Krawczyk","year":"2017","unstructured":"Krawczyk N, Feder KA, Saloner B, Crum RM, Kealhofer M, Mojtabai R. The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a US national sample. Drug Alcohol Depend. 2017;175:157\u201363.","journal-title":"Drug Alcohol Depend"},{"key":"5982_CR58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.addbeh.2011.09.010","volume":"37","author":"TM Kelly","year":"2012","unstructured":"Kelly TM, Daley DC, Douaihy AB. Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav. 2012;37:11\u201324.","journal-title":"Addict Behav"},{"key":"5982_CR59","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1001\/jama.2016.13639","volume":"316","author":"J Knickman","year":"2016","unstructured":"Knickman J, Krishnan R, Pincus H. Improving access to effective care for people with mental health and substance use disorders. JAMA. 2016;316:1647\u20138.","journal-title":"JAMA"},{"key":"5982_CR60","volume-title":"National Survey of Substance Abuse Treatment Services (N-SSATS): 2013. Data on substance abuse treatment facilities. BHSIS Series S-73, HHS Publication No. (SMA) 14\u2013489","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2014","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). National Survey of Substance Abuse Treatment Services (N-SSATS): 2013. Data on substance abuse treatment facilities. BHSIS Series S-73, HHS Publication No. (SMA) 14\u2013489. Rockville: Substance Abuse and Mental Health Services Administration; 2014. \n                    https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/2013_N-SSATS\/2013_N-SSATS_National_Survey_of_Substance_Abuse_Treatment_Services.pdf\n                    \n                  . Accessed 10 Mar 2017"},{"key":"5982_CR61","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1176\/ps.2009.60.1.35","volume":"60","author":"RE Clark","year":"2009","unstructured":"Clark RE, Samnaliev M, McGovern MP. Impact of substance disorders on medical expenditures for Medicaid beneficiaries with behavioral health disorders. Psychiatr Serv. 2009;60:35\u201342.","journal-title":"Psychiatr Serv"},{"key":"5982_CR62","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1001\/archpsyc.59.4.375","volume":"59","author":"D Hasin","year":"2002","unstructured":"Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry. 2002;59:375\u201380.","journal-title":"Arch Gen Psychiatry"},{"key":"5982_CR63","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jsat.2013.07.012","volume":"46","author":"R Mojtabai","year":"2014","unstructured":"Mojtabai R, Chen LY, Kaufmann CN, Crum RM. Comparing barriers to mental health treatment and substance use disorder treatment among individuals with comorbid major depression and substance use disorders. J Subst Abus Treat. 2014;46:268\u201373.","journal-title":"J Subst Abus Treat"},{"key":"5982_CR64","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jsat.2015.09.006","volume":"61","author":"MA Priester","year":"2016","unstructured":"Priester MA, Browne T, Iachini A, Clone S, DeHart D, Seay KD. Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review. J Subst Abus Treat. 2016;61:47\u201359.","journal-title":"J Subst Abus Treat"},{"key":"5982_CR65","unstructured":"United States Census Bureau. QuickFacts. 2018. \n                    https:\/\/www.census.gov\/quickfacts\/fact\/table\/US\/PST045216\n                    \n                  . Accessed 31 May 2018."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-5982-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-018-5982-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-5982-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T12:47:13Z","timestamp":1589460433000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-018-5982-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5982"],"URL":"https:\/\/doi.org\/10.1186\/s12889-018-5982-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"8 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The NIS datasets are publicly available and anonymized. We aggregated the de-identified datasets at the national-level. The use of NIS datasets for research was determined to be exempt from review by the Duke University Health System Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LTW also has received research funding from Patient-Centered Outcomes Research Institute and Alkermes Inc. HZ has no conflict of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1073"}}